Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997;11(3):158-62.
doi: 10.1002/(sici)1098-2825(1997)11:3<158::aid-jcla7>3.0.co;2-6.

Effects of benidipine hydrochloride on antioxidant enzyme activity in stroke-prone spontaneous hypertensive rats (SHR-SP)

Affiliations

Effects of benidipine hydrochloride on antioxidant enzyme activity in stroke-prone spontaneous hypertensive rats (SHR-SP)

I Shou et al. J Clin Lab Anal. 1997.

Abstract

Effects of benidipine hydrochloride or triple therapy (hydralazine, reserpine, and hydrochlorothiazide) on renal cortical and medullary intrinsic antioxidant enzyme (AOE) activity were evaluated in stroke-prone spontaneously hypertensive rats (SHR-SP) as an animal model for human essential hypertension with cerebral stroke. This study showed a significant decrease of renal intrinsic glutathione peroxidase (GSH-Px) activity in untreated SHR-SP. Renal GSH-Px activity in untreated SHR-SP was significantly lower than that in Wister Kyoto rats (WKY) as a normotensive reference strain. GSH-Px activity in SHR-SP was significantly improved after benidipine hydrochloride therapy. Levels of urinary albumin excretion or creatinine clearance (Ccr) in SHR-SP were also improved after the therapy. Glomerular sclerosis index was slightly improved in SHR-SP treated with benidipine hydrochloride according to light microscopic analysis. It appears that hypertension may influence the renal intrinsic GSH-Px activity, albuminuria, and Ccr in SHR-SP. Thus it is indicated that control of blood pressure may improve the GSH-Px activity in SHR-SP.

PubMed Disclaimer

Similar articles

References

    1. Stratta P, Canvese C, Dogliani M, Mazzucco G, Monga G, Vercellone A: The role of free radicals in the progression of renal disease. Kidney Int 17(Suppl.): 33–37, 1991. - PubMed
    1. Shav SV: Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 35: 1093–1106, 1989. - PubMed
    1. Malinski T, Kapturczak M, Dayharsh J, Bohr DF: Nitric oxide synthase activity in genetic hypertension. Biochem Biophys Res Commun 194: 654–658, 1993. - PubMed
    1. Grunfeld S, Hamilton CA, Mesaros S, McClain SW, Dominiczak AF, Bohr DF, Malinski T: Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 26 (part 1): 854–857, 1995. - PubMed
    1. Shou I, Wang LN, Suzuki S, Fukui M, Tomino Y: Effects of antihypertensive drugs on antioxidant enzyme activities in stroke‐prone spontaneous hypertensive rats (SHR‐SP). AJMS (submitted). - PubMed

Publication types

MeSH terms